Physician Assistant, Medical · West Jordan, UT
NPI
1023200888
Since 2007
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3570 W 9000 S Ste 200
West Jordan, UT, 84088
Phone (801) 566-9211
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
87,429 services
Medicare patients, 2024
392
Average age 75
Drug cost, 2024
$371K
605 prescriptions
Company payments, 2025
$4,353
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly D Mikesell was code J1449 (injection, eflapegrastim-xnst, 0.1 mg), 3,168 times for 12 patients. In total Kelly D Mikesell billed 87,429 services in 144 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 3,168 | 12 | $20.64 | $65K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,700 | 18 | $15.56 | $42K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 986 | 22 | $0.09 | $88.71 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 816 | 16 | $0.07 | $59.89 |
| 85025 Blood Count | Office | 775 | 289 | $7.58 | $5,872 |
| 80053 Clinical Chemistry | Office | 577 | 265 | $10.32 | $5,954 |
| 36415 Venipuncture Blood Collection | Office | 536 | 219 | $6.80 | $3,647 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 337 | 202 | $10.29 | $3,469 |
| 82728 Clinical Chemistry | Office | 243 | 104 | $13.36 | $3,246 |
| 83540 Clinical Chemistry | Office | 243 | 103 | $6.34 | $1,541 |
| 83550 Clinical Chemistry | Office | 243 | 103 | $8.57 | $2,083 |
| 99214 Office E&M - Established | Office | 241 | 143 | $73.49 | $18K |
| 99215 Office E&M - Established | Office | 206 | 81 | $113.35 | $23K |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 188 | 12 | $0.42 | $79.3 |
| 83735 Clinical Chemistry | Office | 179 | 58 | $6.57 | $1,176 |
By year: 2022 $738K for 100,287 services; 2023 $1.3M for 131,691 services; 2024 $1.1M for 87,429 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 775 | 289 | $7.58 | $5,872 |
| 80053 Clinical Chemistry | 577 | 265 | $10.32 | $5,954 |
| 36415 Venipuncture Blood Collection | 536 | 219 | $6.80 | $3,647 |
| 83540 Clinical Chemistry | 243 | 103 | $6.34 | $1,541 |
| 82728 Clinical Chemistry | 243 | 104 | $13.36 | $3,246 |
| 83550 Clinical Chemistry | 243 | 103 | $8.57 | $2,083 |
| 83735 Clinical Chemistry | 179 | 58 | $6.57 | $1,176 |
| 82607 Clinical Chemistry | 106 | 76 | $14.66 | $1,554 |
| 82746 Clinical Chemistry | 68 | 63 | $14.23 | $968 |
| 84443 Clinical Chemistry | 53 | 35 | $16.46 | $872 |
Medicare prescription drug claims, 2024
In 2024, the drug Kelly D Mikesell prescribed most often to Medicare patients was Letrozole, with 48 prescriptions and refills. In total Kelly D Mikesell wrote 605 Medicare prescriptions that cost $371K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 48 | 125 | 15 | $985 |
| Eliquis Apixaban | 44 | 64 | Under 11 | $37K |
| Anastrozole Generic | 33 | 87 | Under 11 | $586 |
| Potassium Chloride Generic | 33 | 58 | Under 11 | $1,092 |
| Hydroxyurea Generic | 29 | 59 | Under 11 | $691 |
| Levothyroxine Sodium Generic | 27 | 67 | Under 11 | $301 |
| Prednisone Generic | 24 | 44 | 13 | $174 |
| Tamoxifen Citrate Generic | 20 | 60 | Under 11 | $564 |
| Gabapentin Generic | 20 | 32 | Under 11 | $288 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 19 | 19 | 15 | $602 |
| Ondansetron Hcl Generic | 14 | 20 | Under 11 | $462 |
| Prochlorperazine Maleate Generic | 12 | 12 | Under 11 | $645 |
| Lynparza Olaparib | 12 | 12 | Under 11 | $140K |
| Varenicline Tartrate Generic | 11 | 11 | Under 11 | $3,306 |
| Jadenu Deferasirox | 11 | 11 | Under 11 | $124K |
Brand drugs: 99 claims; generic drugs: 506 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly D Mikesell $4,353 ($4,353 in general payments such as food, travel and fees) from 50 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $501.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $501 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $409 |
| Janssen Biotech, Inc. JNJ | 12 | $302 |
| Daiichi Sankyo Inc. 4568.T | 10 | $279 |
| Incyte Corporation INCY | 7 | $203 |
| Merck Sharp & Dohme LLC MRK | 8 | $178 |
| Pfizer Inc. PFE | 11 | $165 |
| Abbvie Inc. ABBV | 7 | $144 |
| Genmab U.S., Inc. GMAB | 6 | $140 |
| Astellas Pharma US Inc 4503.T | 2 | $123 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.